Literature DB >> 20432236

CD137 ligand signaling induces human monocyte to dendritic cell differentiation.

Shaqireen Kwajah M M1, Herbert Schwarz.   

Abstract

The ligand for CD137 (4-1BB) is expressed on peripheral human monocytes and delivers a potent activating signal via reverse signaling. Here we show that treatment of monocytes with a recombinant CD137 protein that induces reverse signaling through CD137 ligand reduces typical macrophage characteristics such as phagocytosis, oxidative burst and CD14 expression; however, typical DC characteristics including endocytosis, costimulatory molecule expression and the ability to stimulate proliferation of naïve T cells are induced. CD137-generated DC do not express DC-SIGN, CD1a or IL-12 and secrete less IL-10 than classical DC. CD137-generated DC are mature, and addition of LPS+IFN-gamma does not enhance their T-cell-stimulatory capacity. This indicates that CD137 as a sole factor is sufficient to induce development to mature DC, making stimulation of CD137 ligand the most simple protocol to generate mature DC. CD137-generated DC are more potent in inducing T-cell proliferation than classical DC. They inhibit development of Treg cells but induce T-cell expression of perforin, IFN-gamma, IL-13 and IL-17. These data demonstrate that CD137 as a single factor is sufficient to induce differentiation of peripheral monocytes to mature inflammatory DC that have a more potent T-cell-stimulatory capacity than classical DC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20432236     DOI: 10.1002/eji.200940105

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  25 in total

1.  CD137 ligand-mediated reverse signaling inhibits proliferation and induces apoptosis in non-small cell lung cancer.

Authors:  Yingying Qian; Dong Pei; Ting Cheng; Changling Wu; Xiaolin Pu; Xiaofeng Chen; Yiqian Liu; Hong Shen; Weiwei Zhang; Yongqian Shu
Journal:  Med Oncol       Date:  2015-01-29       Impact factor: 3.064

Review 2.  CD137 and CD137L signals are main drivers of type 1, cell-mediated immune responses.

Authors:  Bhushan Dharmadhikari; Meihui Wu; Nur Sharalyn Abdullah; Sakthi Rajendran; Nur Diana Ishak; Emily Nickles; Zulkarnain Harfuddin; Herbert Schwarz
Journal:  Oncoimmunology       Date:  2015-11-11       Impact factor: 8.110

3.  Altered T cell responses in children with autism.

Authors:  Paul Ashwood; Paula Krakowiak; Irva Hertz-Picciotto; Robin Hansen; Isaac N Pessah; Judy Van de Water
Journal:  Brain Behav Immun       Date:  2010-09-15       Impact factor: 7.217

4.  CD137L-stimulated dendritic cells are more potent than conventional dendritic cells at eliciting cytotoxic T-cell responses.

Authors:  Zulkarnain Harfuddin; Shaqireen Kwajah; Adrian Chong Nyi Sim; Paul Anthony Macary; Herbert Schwarz
Journal:  Oncoimmunology       Date:  2013-11-11       Impact factor: 8.110

5.  Intratumoral Activation of 41BB Costimulatory Signals Enhances CD8 T Cell Expansion and Modulates Tumor-Infiltrating Myeloid Cells.

Authors:  Patrick Innamarato; Sarah Asby; Jennifer Morse; Amy Mackay; MacLean Hall; Scott Kidd; Luz Nagle; Amod A Sarnaik; Shari Pilon-Thomas
Journal:  J Immunol       Date:  2020-10-05       Impact factor: 5.422

6.  Differential effects of HIV transmission from monocyte-derived dendritic cells vs. monocytes to IL-17+CD4+ T cells.

Authors:  Yu-Ya Mitsuki; Michael Tuen; Catarina E Hioe
Journal:  J Leukoc Biol       Date:  2016-08-16       Impact factor: 4.962

7.  Regulation of granulocyte and macrophage populations of murine bone marrow cells by G-CSF and CD137 protein.

Authors:  Dongsheng Jiang; Herbert Schwarz
Journal:  PLoS One       Date:  2010-12-13       Impact factor: 3.240

8.  Species difference of CD137 ligand signaling in human and murine monocytes.

Authors:  Qianqiao Tang; Dongsheng Jiang; Zhe Shao; Julia M Martínez Gómez; Herbert Schwarz
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

Review 9.  CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug Development.

Authors:  Kenji Hashimoto
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

10.  CD137 ligand activated microglia induces oligodendrocyte apoptosis via reactive oxygen species.

Authors:  Yee Andy Yeo; Julia M Martínez Gómez; J Ludovic Croxford; Stephan Gasser; Eng-Ang Ling; Herbert Schwarz
Journal:  J Neuroinflammation       Date:  2012-07-16       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.